A recent study found an abundance of mutations in TP53, RB1, and SF3B1 in advanced HCC and patients with a poor prognosis, indicating that mutations in genes governing the cell cycle (TP53, RB1) and the spliceosome machinery (SF3B1) play a significant role in cancer progression [15]. This evidence concerns the gene TP53 and cancer.